59.50
+0.50
+(0.85%)
At close: January 22 at 2:59:43 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-31,614.00
-31,614.00
-34,487.00
-35,989.00
-23,227.00
Investing Cash Flow
33,583.00
33,583.00
18,195.00
52,290.00
19,770.00
Financing Cash Flow
4,316.00
4,316.00
11,450.00
-4,360.00
3,175.00
End Cash Position
21,816.00
21,816.00
15,531.00
20,373.00
8,432.00
Capital Expenditure
-778.00
-778.00
-856.00
-2,885.00
-30.00
Issuance of Capital Stock
10,690.00
10,690.00
17,700.00
--
7,200.00
Free Cash Flow
-32,392.00
-32,392.00
-35,343.00
-38,874.00
-23,257.00
12/31/2020 - 12/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6986.TWO HeXun Biosciences Co., Ltd.
70.00
-0.57%
6610.TWO TWi Biotechnology, Inc.
13.70
+0.74%
7814.TWO HORIEN
29.95
-4.92%
7773.TWO FullHope
41.60
-0.60%
7808.TWO BIONET TX Corp
46.00
-0.33%
4178.TWO StemCyte International, Ltd.
34.20
-0.44%
6704.TWO Gwo Xi Stem Cell Applied Technology Co. , Ltd
27.60
+0.36%
7607.TWO DuoGenic StemCells corporation
18.10
-3.98%
6634.TWO Sinew Pharma Inc.
49.55
+1.12%
7776.TWO Anya
37.35
+0.40%